Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patients

BACKGROUND: Oligoprogression is an emerging issue in patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC). However, the surgical treatment for central nervous system (CNS) oligoprogression is not widely discussed. We investigated the outcomes of craniotomy...

Descripción completa

Detalles Bibliográficos
Autores principales: Perng, Pang-Shuo, Hsu, Heng-Juei, Lee, Jung-Shun, Wang, Liang-Chao, Huang, Chih-Yuan, Tien, Chih-Hao, Lai, Yu-Hsuan, Su, Po-Lan, Hsu, Hao-Hsiang, Chen, Liang-Yi, Lee, Po-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675964/
https://www.ncbi.nlm.nih.gov/pubmed/38007448
http://dx.doi.org/10.1186/s12957-023-03248-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675964/
https://www.ncbi.nlm.nih.gov/pubmed/38007448
http://dx.doi.org/10.1186/s12957-023-03248-7

Ejemplares similares